Holen Sie sich die Stockscreener-App
21.05
1.36%
-0.29
Handel nachbörslich:
21.05
Zenas Biopharma Inc Aktie (ZBIO) Neueste Nachrichten
ZBIO Options Volatility — NASDAQ:ZBIO - TradingView — Track All Markets
ZBIO Options Chain — NASDAQ:ZBIO - TradingView — Track All Markets
Breakout Zone: Will Zenas BioPharma Inc outperform during market ralliesWeekly Investment Recap & Consistent Growth Stock Picks - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zenas BioPharma, Inc. (ZBIO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Zenas BioPharma, Inc. (ZBIO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Big Picture: Is Zenas BioPharma Inc attractive at current valuationTake Profit & Safe Capital Growth Stock Tips - baoquankhu1.vn
Returns Recap: Can Zenas BioPharma Inc be the next market leader2026 Macro Impact & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Trend Review: What is the target price for Zenas BioPharma Inc stock2026 Fed Impact & AI Enhanced Trading Signals - baoquankhu1.vn
Investor Mood: What are Zenas BioPharma Incs growth levers2026 EndofYear Setup & Expert Approved Trade Ideas - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Zenas BioPharma, Inc. (ZBIO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Experienced Healthcare Investor Buys Shares Of Zenas Biopharma – Insider Weekends (NASDAQ:ZBIO) - Seeking Alpha
ZBIO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Assessing Zenas BioPharma (ZBIO) Valuation After US$300 Million Equity And Convertible Notes Financing - Sahm
Zenas BioPharma (ZBIO) Price Target Increased by 21.59% to 40.22 - MSN
Zenas BioPharma's Key Milestones and Market Context: Holding Through the BLA (NASDAQ:ZBIO) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Connect - ACCESS Newswire
Zenas BioPharma Director Makes Bold New Move With Fresh Stock Purchase - TipRanks
Zenas BioPharma Director Increases Stake with $70K Stock Purchase - National Today
Lu Hongbo buys Zenas Biopharma (ZBIO) shares worth $70,197 By Investing.com - Investing.com Canada
Lu Hongbo buys Zenas Biopharma (ZBIO) shares worth $70,197 - Investing.com
Insider Buying: Zenas BioPharma (NASDAQ:ZBIO) Director Buys 3,768 Shares of Stock - marketbeat.com
Leon Moulder boosts Zenas BioPharma (ZBIO) stake to 4.794% ownership - Stock Titan
Zenas BioPharma (ZBIO) director-affiliated funds purchase 3,768 shares - Stock Titan
Zenas BioPharma (NASDAQ:ZBIO) Trading Up 7.6% Following Insider Buying Activity - MarketBeat
2026-04-02 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Connect | NDAQ:ZBIO | Press Release - Stockhouse
Zenas BioPharma (NASDAQ:ZBIO) Director Purchases $3,000,000.00 in Stock - MarketBeat
Akin, an Elite Global Law Firm - Akin
Zenas BioPharma (ZBIO): Does This $300 Million Raise Clarify or Complicate Its Funding Strategy? - Sahm
Major Insider Move Signals Growing Confidence in Zenas BioPharma’s Future - TipRanks
Zenas Biopharma, Daqo New Energy and other big stocks moving lower in Friday's pre-market session - MSN
Fairmount fund adds 150,000 Zenas BioPharma (ZBIO) shares - Stock Titan
ZBIO6353884 Bond Price and Chart — FINRA:ZBIO6353884 - TradingView
Zenas BioPharma, Inc. Bonds — Corporate Bond Rates - TradingView — Track All Markets
Zenas BioPharma Insider Bought Shares Worth $1,021,140, According to a Recent SEC Filing - marketscreener.com
Insider Makes Bold Million-Dollar Bet on Zenas BioPharma - TipRanks
Bronstein, Gewirtz & Grossman, LLC Encourages Zenas BioPharma, Inc. (ZBIO) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
ZBIO Stock Price and Chart — NASDAQ:ZBIO - TradingView
54K-share open-market buy by CEO-linked entities at Zenas BioPharma (ZBIO) - Stock Titan
Zenas BioPharma Raises Capital via Notes and Equity Offering - TipRanks
Zenas BioPharma (ZBIO) CEO Moulder buys shares worth $1.02 million By Investing.com - Investing.com Australia
Zenas BioPharma (ZBIO) CEO Moulder buys shares worth $1.02 million - investing.com
Lu Hongbo buys $1.5 million in Zenas Biopharma (ZBIO) stock - Investing.com
Lu Hongbo buys $1.5 million in Zenas Biopharma (ZBIO) stock By Investing.com - Investing.com Canada
Director-linked funds add 75K Zenas BioPharma (ZBIO) shares at $20 in offering - Stock Titan
Zenas BioPharma (ZBIO) raises capital via $200M converts and equity sale - Stock Titan
Form 424B5 Zenas BioPharma, Inc. - StreetInsider
Zenas BioPharma (NASDAQ: ZBIO) prices $200M convertible notes due 2032 - Stock Titan
[424B5] Zenas BioPharma, Inc. Prospectus Supplement (Debt Securities) - Stock Titan
InnoCare Hits Profit Milestone, Relative Undervaluation Points To Stock Upside - Benzinga
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zenas BioPharma, Inc. (ZBIO) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Zenas BioPharma announces concurrent public offerings of convertible senior notes and common stock - MSN
Zenas BioPharma Funding Shifts Focus From Survival Risk To Execution Risk - Yahoo Finance
Zenas BioPharma prices $300M capital raise in dual offering - MSN
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap DownShould You Sell? - MarketBeat
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
2.69%
0.25%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):